HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Persistent Legionnaire's disease in an adult with hairy cell leukemia successfully treated with prolonged levofloxacin therapy.

Abstract
Legionnaire's disease (LD) manifests most commonly as an atypical community acquired pneumonia (CAP) with systemic extrapulmonary manifestations. Disorders associated with impaired cell mediated immunity (CMI) are particularly predisposed to LD. Hairy cell leukemia (HCL) is a rare B-cell lymphoproliferative leukemia associated with decreased CMI. LD has only rarely been reported in HCL. We present a most interesting case of persistent LD in a elderly male with HCL who required prolonged antibiotic therapy.
AuthorsBurke A Cunha, Sigridh Munoz-Gomez, Arthur Gran, Muhammad Raza, Nadia Irshad
JournalHeart & lung : the journal of critical care (Heart Lung) 2015 Jul-Aug Vol. 44 Issue 4 Pg. 360-2 ISSN: 1527-3288 [Electronic] United States
PMID26021547 (Publication Type: Case Reports, Journal Article)
CopyrightCopyright © 2015 Elsevier Inc. All rights reserved.
Chemical References
  • Anti-Bacterial Agents
  • Levofloxacin
Topics
  • Aged
  • Anti-Bacterial Agents (therapeutic use)
  • Chronic Disease
  • Community-Acquired Infections (complications, drug therapy)
  • Humans
  • Legionnaires' Disease (complications)
  • Leukemia, Hairy Cell (complications, drug therapy)
  • Levofloxacin (therapeutic use)
  • Male
  • Pneumonia, Bacterial (complications, drug therapy)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: